Danazol mediates collateral sensitivity via STAT3/Myc related pathway in multidrug-resistant cancer cells.
Ontology highlight
ABSTRACT: Multidrug resistance presents an obstacle in cancer treatment. Among numerous combative strategies, collateral sensitivity (CS) drugs have opened a new avenue to defeat cancer by exploiting selective toxicity against multidrug-resistant (MDR) cancer. In the present study, a clinically used synthetic steroid hormone, danazol, was investigated for its CS properties and cytotoxic mechanisms. Compared with natural hormones, danazol possessed a stronger selective cytotoxicity against MDR cancer cells. Danazol induced the arrest of MDR cancer cells at the G2/M phase and caspase-8-related early apoptosis. Furthermore, in MDR cancer cells, danazol reduced STAT3 phosphorylation as well as the expression of STAT3-regulated genes involved in cell survival, such as c-Myc, CDC25, and CDK1. Danazol also
SUBMITTER: Chang YT
PROVIDER: S-EPMC6690972 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA